Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Amerika
Acelyrin Inc
Nieuws
Acelyrin Inc
SLRN
NAS
: SLRN
| ISIN: US00445A1007
31/05/2024
4,120 USD
(+1,73%)
(+1,73%)
31/05/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
15 januari 2024 ·
FINAL SLRN DEADLINE: Bronstein, Gewirtz & Grossman LLC Announces that ACELYRIN, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
· Persbericht
12 januari 2024 ·
SLRN Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Acelyrin, Inc. (SLRN) of Deadline in Securities Fraud Class Action Lawsuit
· Persbericht
11 januari 2024 ·
Acelyrin Investor Deadline Approaching
· Persbericht
11 januari 2024 ·
SLRN Investors Have Opportunity to Lead ACELYRIN, Inc. Securities Fraud Lawsuit
· Persbericht
4 januari 2024 ·
ACELYRIN INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options
· Persbericht
30 december 2023 ·
SLRN CLASS ACTION ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Announces Securities Class Action Lawsuit Filed Against Acelyrin, Inc. (SLRN)
· Persbericht
28 december 2023 ·
SLRN Investors Have Opportunity to Lead ACELYRIN, Inc. Securities Fraud Lawsuit
· Persbericht
28 december 2023 ·
ACELYRIN INVESTOR DEADLINE APPROACHING : Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options
· Persbericht
21 december 2023 ·
ACELYRIN INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options
· Persbericht
20 december 2023 ·
Attention SLRN Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against Acelyrin, Inc. (SLRN) and Encourages Investors to Contact the Firm
· Persbericht
14 december 2023 ·
ACELYRIN INVESTOR DEADLINE APPROACHING: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options
· Persbericht
13 december 2023 ·
SLRN Investors Have Opportunity to Lead ACELYRIN, Inc. Securities Fraud Lawsuit
· Persbericht
12 december 2023 ·
DiCello Levitt LLP Announces Investor Class Action Lawsuit Filed Against Acelyrin, Inc. (NASDAQ: SLRN) and Lead Plaintiff Deadline
· Persbericht
11 december 2023 ·
Kessler Topaz Meltzer & Check, LLP Reminds Acelyrin, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
· Persbericht
5 december 2023 ·
ACELYRIN SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Acelyrin To Contact Him Directly To Discuss Their Options
· Persbericht
2 december 2023 ·
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Acelyrin, Inc.
· Persbericht
10 oktober 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acelyrin, Inc. - SLRN
· Persbericht
29 september 2023 ·
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Acelyrin, Inc. - SLRN
· Persbericht
9 mei 2023 ·
ACELYRIN, INC. Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe